Home
Noxopharm Ltd
FDA allows Veyonda Pre-IND Submission for COVID-19
Business
May 19 2020
3 min read

FDA allows Veyonda Pre-IND Submission for COVID-19

news images

Noxopharm Ltd has released a press release.

View Attachment